We are live on
!
Find out more
Boston Partners Portfolio holdings
AUM
$95.5B
1-Year Est. Return
28.4%
This Fund
S&P 500
This Quarter
Est. Return
+1.76%
1 Year Est. Return
+28.4%
3 Year Est. Return
+84.58%
5 Year Est. Return
+116.72%
10 Year Est. Return
+426.49%
AUM
$82.7B
AUM Growth
+$473M
(+0.58%)
Cap. Flow
+$823M
Cap. Flow
% of AUM
0.99%
Top 10 Holdings %
Top 10 Hldgs %
14.9%
Holding
783
New
76
Increased
301
Reduced
323
Closed
81
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Coca-Cola
KO
|
+$598M |
| 2 |
Apollo Global Management
APO
|
+$418M |
| 3 |
Allstate
ALL
|
+$416M |
| 4 |
SCHW
Charles Schwab
SCHW
|
+$385M |
| 5 |
Quest Diagnostics
DGX
|
+$377M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amgen
AMGN
|
+$431M |
| 2 |
Delta Air Lines
DAL
|
+$318M |
| 3 |
Deere & Co
DE
|
+$282M |
| 4 |
Robert Half
RHI
|
+$270M |
| 5 |
Curtiss-Wright
CW
|
+$265M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 21.07% |
| 2 | Technology | 14.6% |
| 3 | Industrials | 13.72% |
| 4 | Healthcare | 11.92% |
| 5 | Consumer Discretionary | 8.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
651
Crawford & Co Class A
CRD.A
$551M
| $418K | ﹤0.01% |
36,641
-2,972
| -8% | -$34.7K |
|
652
Stoneridge
SRI
$208M
| $410K | ﹤0.01% |
89,267
+18,065
| +25% | +$91.9K |
|
653
Kaltura
KLTR
$217M
| $409K | ﹤0.01% |
217,774
-315,187
| -59% | -$705K |
|
654
Natural Gas Services Group
NGS
$460M
| $406K | ﹤0.01% |
18,488
+138
| +0.8% | +$3.49K |
|
655
RCM Technologies
RCMT
$205M
| $398K | ﹤0.01% |
25,521
+1,023
| +4% | +$19.1K |
|
656
CareDx
CDNA
$1.85B
| $381K | ﹤0.01% |
21,457
+158
| +0.7% | +$3.4K |
|
657
Ranpak Holdings
PACK
$550M
| $378K | ﹤0.01% |
69,720
-10,659
| -13% | -$70.1K |
|
658
Algoma Steel
ASTL
$463M
| $375K | ﹤0.01% |
69,258
-1,058
| -2% | -$7.95K |
|
|
BOW
659
Bowhead Specialty Holdings
BOW
$1.06B
| $370K | ﹤0.01% |
9,098
-2,401
| -21% | -$81.8K |
|
|
NESR
660
National Energy Services Reunited Corp
NESR
$2.58B
| $361K | ﹤0.01% |
+49,105
| New | +$424K |
|
661
AerSale
ASLE
$307M
| $357K | ﹤0.01% |
47,633
-28,832
| -38% | -$206K |
|
662
Central Pacific Financial
CPF
$1.02B
| $354K | ﹤0.01% |
13,089
+96
| +0.7% | +$2.71K |
|
663
Tiptree Inc
TIPT
$678M
| $353K | ﹤0.01% |
14,655
-10,397
| -42% | -$221K |
|
664
RGC Resources
RGCO
$239M
| $347K | ﹤0.01% |
16,630
+125
| +0.8% | +$2.57K |
|
|
CSR
665
Centerspace
CSR
$941M
| $342K | ﹤0.01% |
5,284
-48
| -0.9% | -$3.03K |
|
|
ALE
666
DELISTED
Allete
ALE
| $328K | ﹤0.01% |
4,997
-22,931
| -82% | -$1.5M |
|
667
Viemed Healthcare
VMD
$457M
| $321K | ﹤0.01% |
44,078
+328
| +0.7% | +$2.58K |
|
668
BlackBerry
BB
$4.74B
| $321K | ﹤0.01% |
85,106
-281,122
| -77% | -$1.28M |
|
669
Coherent
COHR
$47.6B
| $318K | ﹤0.01% |
+4,893
| New | +$405K |
|
670
Hallador Energy
HNRG
$689M
| $308K | ﹤0.01% |
25,108
-4,142
| -14% | -$46.5K |
|
671
Constellation Energy
CEG
$92.8B
| $303K | ﹤0.01% |
+1,502
| New | +$403K |
|
672
Wabash National
WNC
$541M
| $290K | ﹤0.01% |
+26,237
| New | +$352K |
|
673
Ranger Energy Services
RNGR
$345M
| $286K | ﹤0.01% |
20,156
-1,502
| -7% | -$24.3K |
|
674
Babcock & Wilcox
BW
$1.31B
| $274K | ﹤0.01% |
406,945
-86,368
| -18% | -$107K |
|
675
Consensus Cloud Solutions
CCSI
$683M
| $272K | ﹤0.01% |
11,772
-2,581
| -18% | -$66.4K |
|
Similar funds
Boston Partners's Q1 2025 Portfolio in Review
As of Q1 2025, Boston Partners held 783 positions worth $82.7B, up 0.58% from $82.2B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Boston Partners's Q1 2025 filing shows 76 new, 301 increased, 323 reduced and 81 closed positions. Its largest new stake was Coca-Cola: 8,951,766 shares worth $642M. The largest sale was Amgen, an estimated $431M.
By sector, the portfolio is most concentrated in Financials at 21% of assets, up from 21% a quarter earlier, followed by Technology and Industrials.
- Boston Partners's largest Q1 2025 buy was Coca-Cola: 8,951,766 shares worth $642M.
- Boston Partners added most to Allstate in Q1 2025, an estimated $416M increase.
- Boston Partners's biggest Q1 2025 reduction was Amgen, cutting an estimated $431M.
- Boston Partners fully exited Hologic in Q1 2025, selling an estimated $258M.
- Boston Partners's ten largest holdings make up 15% of its $82.7B portfolio in Q1 2025.
- Boston Partners opened 76 new positions and closed 81 in Q1 2025.
- Boston Partners's portfolio value rose 0.58% quarter-over-quarter to $82.7B.
Based on Boston Partners's 13F filing for Q1 2025, filed 13 May 2025.